Search

You searched for "therapeutics"

481 results found

In this issue...Inner Ear Therapeutics

2 September 2022 |
Emma Stapleton, MBChB, FRCS (ORL-HNS), Consultant Otolaryngologist, Cochlear Implant and Skull Base Surgeon, Manchester Royal Infirmary, UK. E: emmastapleton@doctors.org.ukTwitter: @otolaryngolofox Ralph Holme, Director of Research and Insight, RNID, UK. Ralph. E: Holme@rnid.org.uk W: www.rnid.org.uk For Mar/Apr 2022, we sang the...

Cochlear implants and therapeutics: a natural partnership?

2 September 2022 | | ENTA - ENT, ENTA - Auditory Implants
Global awareness of cochlear implants as a solution for hearing loss is slowly increasing and gaining acceptance. The potential for combining cochlear implants with inner ear therapeutics is immense, with promise in several areas. This article takes us on a...

Mind the gap – developing a sustainable pipeline for hearing therapeutics

2 September 2022 | | ENTA - Audiology - Adult, ENTA - Otology
In this article, the authors describe three key challenges faced in developing hearing therapeutics. Collaboration between companies, sectors and disciplines will be key to finding solutions. The unmet need for therapies for hearing loss grows apace, with prevalence rising across...

The changing landscape for hearing loss therapeutics: novel advances of gene and cell therapies

3 September 2024 | | ENTA - Audiology - Adult
Recent years have seen advances in hearing loss therapeutics, with novel treatments trialled in humans, and others nearing promising first-in-kind clinical trials. First successful clinical trials for a specific form of genetic hearing loss Very exciting news has emerged in...

A drug to prevent hearing loss caused by ototoxic therapeutics

1 November 2016 |
This editorial briefly highlights the progress made in discovering a compound named ORC-13661, which shows the potential to alter the response of hair cells to ototoxic medication. In the late 1980s, inner hair cells that were lost secondary to noise...

5th Annual Inner Ear Disorders Therapeutics Summit

15 July 2025 -17 July 2025 | ENTA - Genetics, ENTA - Vestibular Disorders, ENTA - Otology, ENTA - Audiology - Adult, ENTA - Audiology - Paediatric
Coined by industry as the only meeting of its kind and uniquely positioned to share fresh ideas and assess viable approaches to your most pressing preclinical, translational, and clinical bottlenecks, the 5th Inner Ear Disorders Summit returns as a forum to benchmark learnings from past failures, reignite momentum and develop investment into the audiology therapeutic landscape.

4th Annual Inner Ear Disorders Therapeutics Summit

20 August 2024 -22 August 2024
Terrri Gaskell, Chief Technology Officer, Rinri TherapueticsHeld in Boston, USA, this was an essential gathering that captured the growing excitement in both the biotech and clinical communities surrounding the rapid advancements in hearing loss therapies. With the potential to significantly...

3rd International Symposium on Inner Ear Therapeutics

28 April 2023 -30 April 2023 | ENTA - ENT, Otology
L’Institut de l’Audition (Centre Pasteur, Paris) and the International Society for Inner Ear Therapeutics (ISIET), with de collaboration with ENT-HNS Moroccan Collège (CEMORL), are organising the 3rd International Symposium on Inner Ear Therapeutics entitled ‘Inner Ear Therapeutics: Updates and Challenges...

Implantation Otology & Inner Ear Therapeutics Issue I

To skip directly to features, click the links below: Welcome from the editor - by Prof Manohar Bance Industry News Genomic therapies for hearing loss - by Manohar Bance Cell-based therapies - by Jennifer Harre, Athanasia Warnecke, Hinrish Staecker, Eva...

3rd Annual Inner Ear Disorders Therapeutics Summit

29 August 2023 -31 August 2023 | Otology, ENTA - ENT
The development of next-generation drug-based approaches to treat inner ear disorders is gaining momentum, with multiple INDs approved in the last six months and big pharma making plays to acquire innovative biotechs working on hearing loss. The 3rd Inner Ear...

Team proves secure pathway to the inner ear

5 December 2022
An international team of surgeons and scientists has, for the first time, validated safe surgical access to the central core of the human cochlea.

Rethinking tinnitus ‘care’: the role of digital solutions

4 March 2025 | | ENTA - Tinnitus
Experiencing tinnitus can be very distressing and accessible care is limited. Digital therapeutics is one way of addressing these concerns, as described by Dr Bardy. Tinnitus presents a significant clinical challenge for various healthcare professionals, including general practitioners (GPs), ENTs...